Open AccessAre the current evaluation tools for advanced therapies biased?
Author(s) -
Raymond C. Givens
Publication year - 2021
Publication title -
current opinion in cardiology/current opinion in cardiology, with evaluated medline
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.826
H-Index - 78
eISSN - 1080-787X
pISSN - 0268-4705
DOI - 10.1097/hco.0000000000000848
Subject(s) - medicine , psychosocial , battle , racism , health equity , health care , intensive care medicine , covid-19 , diversity (politics) , nursing , psychiatry , public health , economic growth , disease , pathology , archaeology , sociology , political science , anthropology , infectious disease (medical specialty) , law , economics , history
Despite attention to racial disparities in outcomes for heart failure (HF) and other chronic diseases, progress against these inequities has been gradual at best. The disparities of COVID-19 and police brutality have highlighted the pervasiveness of systemic racism in health outcomes. Whether racial bias impacts patient access to advanced HF therapies is unclear.